Vasopressin V2 receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vasopressin V2 receptor antagonist, covering 2008-06-17 to 2008-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT). [Phase 2]